The effect of Xenical [orlistat] on weight, risk factors and burden of medication.
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2013
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned End Date changed from 1 Dec 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.